Rack, S.; Feeney, L.; Hapuarachi, B.; Adderley, H.; Woodhouse, L.; Betts, G.; Burghel, G.J.; Harrington, K.J.; Metcalf, R.
Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer. Cancers 2022, 14, 1133.
https://doi.org/10.3390/cancers14051133
AMA Style
Rack S, Feeney L, Hapuarachi B, Adderley H, Woodhouse L, Betts G, Burghel GJ, Harrington KJ, Metcalf R.
Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer. Cancers. 2022; 14(5):1133.
https://doi.org/10.3390/cancers14051133
Chicago/Turabian Style
Rack, Samuel, Laura Feeney, Brindley Hapuarachi, Helen Adderley, Laura Woodhouse, Guy Betts, George J. Burghel, Kevin J. Harrington, and Robert Metcalf.
2022. "Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer" Cancers 14, no. 5: 1133.
https://doi.org/10.3390/cancers14051133
APA Style
Rack, S., Feeney, L., Hapuarachi, B., Adderley, H., Woodhouse, L., Betts, G., Burghel, G. J., Harrington, K. J., & Metcalf, R.
(2022). Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer. Cancers, 14(5), 1133.
https://doi.org/10.3390/cancers14051133